Combinostics is a brand that combines their extensive knowledge of neurological conditions, their passion for innovative technology, and their partnerships with clinical care centers to develop new solutions that fill the gaps in clinical care. Their main goal is to provide accurate and early diagnoses for patients with neurological disorders, ultimately improving the quality of life for both patients and their families/caregivers. Using their collective history of science and research, Combinostics utilizes artificial intelligence and insights from clinical care centers to innovate new ways to support clinicians in providing the best care for their patients.

Their flagship product, cNeuro, has been praised by current customers for providing the necessary information for confident, evidence-based decisions. Continually looking forward, Combinostics aims to address the next challenge, whether it's aiding with patient selection for clinical trials or empowering patients with tools to improve their own health. Based in Finland, Combinostics takes pride in their Nordic background and close relationships with leading institutions.

They have a strong leadership team and a dedicated team of professionals, including clinical application specialists, imaging scientists, and software developers. Combinostics also has a renowned Medical Advisory Board consisting of top experts in the field. With their innovative solutions and commitment to advancing patient care, Combinostics is at the forefront of neurological healthcare